Relay Therapeutics, Inc. (RLAY)
10.26
+1.10
(+12.01%)
USD |
NASDAQ |
Feb 27, 16:00
10.29
+0.03
(+0.29%)
After-Hours: 20:00
Relay Therapeutics EPS Diluted (Quarterly) : -0.4301 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | -0.5006 |
| Spyre Therapeutics, Inc. | -0.6903 |
| Eli Lilly & Co. | 7.024 |
| Celcuity, Inc. | -0.9204 |
| Revolution Medicines, Inc. | -1.855 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.15M |
| Total Expenses (Quarterly) | 74.15M |
| Enterprise Value | 1.215B |
| Earnings Yield | -17.06% |
| Normalized Earnings Yield | -17.06 |